SHS Capital
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity
Stage Focus
Growth, Buyout, Turnaround, Distressed
Geographical Focus
United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Luxembourg, Ireland, Austria, Netherlands, Hungary, Portugal, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Slovakia, Romania
Industries Focus
- Healthcare
- Healthcare Services
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Medical Research
- Medical Equipment
- Health Technology
- Medical Technology
- Health Insurance
- Healthcare IT
- Health IT
- Medical Supplies
- Rehabilitation
- Medical Consulting
- Home Care
- Surgical Instruments
- Patient Care
- Clinical Services
- Therapeutic Devices
Investment Size:
10,000,000 to 50,000,000 USD
Investor Details Founded: 1993
SHS Capital is a private equity firm based in Tübingen, Germany, specializing in investments within the European healthcare sector. Founded in 1993, the firm focuses on supporting fast-growing companies aiming to become European healthcare champions. With over 30 years of experience, SHS Capital has established itself as a leading German healthcare-dedicated private equity fund, having invested in more than 75 companies and completed over 50 exits since its inception. The firm's investment philosophy centers on 'Building European Healthcare Champions,' emphasizing the development and growth of portfolio companies in the healthcare industry.
The firm's investment strategy involves both majority and minority stakes, targeting companies in growth situations, including SMEs and scale-ups. SHS Capital typically invests between €10 million and €50 million per transaction, with enterprise values up to €150 million. The firm's core geographies include the DACH region (Germany, Austria, Switzerland), the Nordics, and the Benelux countries, though it also selectively considers opportunities in other European countries. SHS Capital's expertise spans various areas, including market access, reimbursement, marketing/sales, M&A, and exit strategies, providing comprehensive support to its portfolio companies.
In September 2023, SHS Capital closed its sixth fund generation (SHS VI) with a volume of approximately €270 million, significantly exceeding its initial target of €200 million. This fund aims to make ten to fifteen investments in growing European healthcare companies, with a focus on expansion financing, shareholder changes, and succession situations. The firm's investor base comprises private and institutional investors, including family offices, pension funds, foundations, and strategic investors, reflecting a strong commitment to the healthcare sector and a long-term investment approach.
Requirements
- Healthcare companies in growth situations
- Companies aiming to become European healthcare champions
- Enterprises with enterprise values up to €150 million
- Businesses seeking expansion financing, shareholder changes, or succession planning
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Ackermann Instrumente GmbH
- Medizintechnik Rostock GmbH
- Selfapy GmbH
- Medigroba GmbH
- MTRonline.de
Mentioned In
-
$19.95
-
$19.95
-
$39.95
-
$245.00
Claim this Investor
Are you an official representative of SHS Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim